MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds

thought leadership

Cell and gene therapy in the Asia-Pacific region: learnings from local case studies

Sudha Sundaram, Vesshnu Sutharsan, and Ye Huang | 2/20/2024

In this second update in our series, we share two case studies that explore how local innovators in the cell and gene therapy (CGT) space in Asia-Pacific (APAC) are addressing some of the major challenges for access in the region: that of overcoming complex manufacturing and delivery and improving affordability. 

Many local players are advancing technology and improving access for cell and gene therapies in the Asia-Pacific region

APAC markets were some of the first globally to embrace CGTs, with China approving the world’s first gene therapy way back in 2003. Today, markets in the APAC region have a relatively large pharmaceutical expenditure, with China and Japan ranking among the five largest global pharmaceutical markets.

The region’s large and aging populations are driving an increasing demand for innovative therapies, including CGTs; APAC is estimated to have a compound annual growth rate of 56% over a 5-year period until 2026 for chimeric antigen receptor T-cell therapy (CAR-T) alone (vs a global CAGR of 39%).

Given the commercial potential of CGTs as innovative, life-changing therapies for patients in the region and beyond, it is no surprise that many local players have become actively engaged in advancing CGT technology and improving CGT access in the APAC region.


Overcoming manufacturing, delivery, and affordability challenges for cell and gene therapies in the Asia-Pacific region

Here are two case studies that explain how local innovators are addressing the major access challenges of overcoming complex manufacturing and delivery and improving affordability for CGTs in APAC.


This biotech company in the Asia-Pacific region is leveraging regional and public-private partnerships to establish cost-effective and scalable localized manufacturing in the cell and gene therapy space.

Vesshnu Sutharsan


avatar for Vesshnu Sutharsan - Consultant


Case study 1: A spotlight on India

Asia-Pacific Cell and Gene Therapy


This biopharmaceutical manufacturer is leveraging city-level voluntary commercial health insurance to accelerate the adoption of transformative cell and gene therapies among patients in the Asia-Pacific region.

Ye Huang

Senior Consultant

avatar for Ye Huang - Senior Consultant


Case study 2: A spotlight on China 

Asia-Pacific Cell and Gene Therapy


Connect with us and stay at the forefront of advancements in the cell and gene therapy space in the AsiaPacific region 

To learn more about the evolving competitive landscape of CGTs in APAC and gain insights into the CGT capabilities of local biotechs and where their products are today, watch our webinar, “Exploring new horizons: Cell and gene therapy access in the Asia-Pacific region”. Alternatively, please contact our policy, access, value, and evidence experts in Singapore. 

We care about your privacy

By clicking "Accept all cookies", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Manage my preferences

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Avalere Health website, such as the pages you visit.

For more information, check the cookie statement


Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.